Search results
O28.5 is a billable diagnosis code used to specify a medical diagnosis of abnormal chromosomal and genetic finding on antenatal screening of mother. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
1 paź 2022 · O35.13X1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Mat care chromosomal abnlt in fetus, Trisomy 21, fetus 1; The 2025 edition of ICD-10-CM O35.13X1 became effective on October 1, 2024.
The screening blood tests themselves have no adverse effects for the woman, over and above the risks of a routine blood test. However some women who have a “high risk” screening test result, and are given amniocentesis or CVS have a risk of miscarrying a baby unaffected by Down's.
30 lis 2015 · Mothers with pregnancies identified as high risk for Down's syndrome by serum testing are often offered immediate definitive testing by amniocentesis, whereas those considered low risk are assessed for Down's syndrome by inspection at birth.
8 mar 2018 · Blood test. This blood test measures the levels of pregnancy-associated plasma protein-A (PAPP-A) and the pregnancy hormone known as human chorionic gonadotropin (HCG). Abnormal levels of PAPP-A and HCG may indicate a problem with the baby. Nuchal translucency test.
ICD-10 code O35.1 for Maternal care for (suspected) chromosomal abnormality in fetus is a medical classification as listed by WHO under the range - Pregnancy, childbirth and the puerperium . Official Long Descriptor. Maternal care for (suspected) chromosomal abnormality in fetus. O35.
